NEW YORK (GenomeWeb) – Enterome and Synthetic Biologics will conduct microbiome research on the effects of beta-lactam antibiotics on humans as part of an agreement announced today.

The deal includes a clinical microbiome study of about 100 patients anticipated to begin in July, which could aid Synthetic Biologics as it further develops SYN-004 for protecting the gut microbiome from the effects of intravenous beta-lactam antibiotics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.